Your browser doesn't support javascript.
loading
Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer.
Wang, H; Agulnik, J; Kasymjanova, G; Wang, A; Jiménez, P; Cohen, V; Small, D; Pepe, C; Sakr, L; Fiset, P O; Auger, M; Camilleri-Broet, S; Alam El Din, M; Chong, G; van Kempen, L; Spatz, A.
Afiliação
  • Wang H; Divisions of Pathology & Molecular genetics, OPTILAB-McGill University Health Center, Montreal, Canada; Department of Pathology, McGill University, Montreal, Canada; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada. Electronic address: hangjun.wang@mcg
  • Agulnik J; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada; Department of Oncology, McGill University, Montreal, Canada.
  • Kasymjanova G; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada; Department of Oncology, McGill University, Montreal, Canada.
  • Wang A; Department of Oncology, McGill University, Montreal, Canada.
  • Jiménez P; National University of AsunciœFaculty of Medical Sciences, Dr. Montero, 658. AsunciœParaguay.
  • Cohen V; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada; Department of Oncology, McGill University, Montreal, Canada.
  • Small D; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada.
  • Pepe C; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada.
  • Sakr L; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada.
  • Fiset PO; Divisions of Pathology & Molecular genetics, OPTILAB-McGill University Health Center, Montreal, Canada; Department of Pathology, McGill University, Montreal, Canada.
  • Auger M; Divisions of Pathology & Molecular genetics, OPTILAB-McGill University Health Center, Montreal, Canada; Department of Pathology, McGill University, Montreal, Canada.
  • Camilleri-Broet S; Divisions of Pathology & Molecular genetics, OPTILAB-McGill University Health Center, Montreal, Canada; Department of Pathology, McGill University, Montreal, Canada.
  • Alam El Din M; Divisions of Pathology & Molecular genetics, OPTILAB-McGill University Health Center, Montreal, Canada; Department of Pathology, McGill University, Montreal, Canada.
  • Chong G; Divisions of Pathology & Molecular genetics, OPTILAB-McGill University Health Center, Montreal, Canada; Department of Pathology, McGill University, Montreal, Canada.
  • van Kempen L; Divisions of Pathology & Molecular genetics, OPTILAB-McGill University Health Center, Montreal, Canada; Department of Pathology, McGill University, Montreal, Canada; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada.
  • Spatz A; Divisions of Pathology & Molecular genetics, OPTILAB-McGill University Health Center, Montreal, Canada; Department of Pathology, McGill University, Montreal, Canada; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, Canada; Department of Oncology, McGill Unive
Ann Oncol ; 29(6): 1417-1422, 2018 06 01.
Article em En | MEDLINE | ID: mdl-29659668

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Carcinoma de Células Escamosas / Adenocarcinoma / Carcinoma Pulmonar de Células não Pequenas / Citodiagnóstico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Carcinoma de Células Escamosas / Adenocarcinoma / Carcinoma Pulmonar de Células não Pequenas / Citodiagnóstico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article